Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Salarius Pharmaceuticals Notified By MD Anderson Cancer Center Of Grade 4 Adverse Event In Seclidemstat Clinical Trial; FDA Places Trial On Partial Clinical Hold; No New Patients Enrolled, Current Patients May Continue Treatment; Company To Support Data Analysis And Respond To FDA Queries

Author: Benzinga Newsdesk | July 11, 2024 08:19am

- 8K Filing

Posted In: SLRX